LB-17. Efficacy of Hydroxychloroquine (HCQ) for Post-exposure Prophylaxis to Prevent Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Blinded, Randomized, Controlled Trial

BACKGROUND: Prevention interventions for coronavirus disease (COVID-19), caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), are currently limited to non-pharmaceutical strategies. Observational and laboratory data suggested that hydroxychloroquine (HCQ) had biologic activity aga...

Descripción completa

Detalles Bibliográficos
Autores principales: Brown, Elizabeth R, Bershteyn, Anna, Karita, Helen C Stankiewicz, Johnston, Christine, Thorpe, Lorna, Kottkamp, Angelica, Neuzil, Kathleen, Laufer, Miriam K, Deming, Meagan, Paasche-Orlow, Michael K, Kissinger, Patricia J, Luk, Alfred, Paolino, Kristopher M, Landovitz, Raphael J, Hoffman, Risa, Schaafsma, Torin, Krows, Meighan L, Thomas, Katherine, Morrison, Susan, Kidoguchi, Lara, Wener, Mark H, Greninger, Alexander L, Huang, Meei-Li, Jerome, Keith, Wald, Anna, Celum, Connie, Chu, Helen Y, Baeten, Jared M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Late Breaker Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776476/
http://dx.doi.org/10.1093/ofid/ofaa515.1914

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776476/
http://dx.doi.org/10.1093/ofid/ofaa515.1914

Ejemplares similares